Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol is derived from testosterone, and has been abused by several high profile professional athletes.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Stanozolol is combined with Cyclosporine. |
| Dicoumarol | Stanozolol may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Stanozolol may increase the anticoagulant activities of Phenindione. |
| Warfarin | Stanozolol may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Stanozolol may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Stanozolol may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Stanozolol may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Stanozolol may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Stanozolol may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Stanozolol may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Stanozolol may increase the anticoagulant activities of Fluindione. |
| Clorindione | Stanozolol may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Stanozolol may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Stanozolol may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Stanozolol may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | Stanozolol may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Stanozolol may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Stanozolol may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Stanozolol may increase the hypoglycemic activities of Insulin pork. |
| Troglitazone | Stanozolol may increase the hypoglycemic activities of Troglitazone. |
| Glimepiride | Stanozolol may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | Stanozolol may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | Stanozolol may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | Stanozolol may increase the hypoglycemic activities of Acarbose. |
| Metformin | Stanozolol may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | Stanozolol may increase the hypoglycemic activities of Sulfadiazine. |
| Rosiglitazone | Stanozolol may increase the hypoglycemic activities of Rosiglitazone. |
| Acetohexamide | Stanozolol may increase the hypoglycemic activities of Acetohexamide. |
| Quinine | Stanozolol may increase the hypoglycemic activities of Quinine. |
| Miglitol | Stanozolol may increase the hypoglycemic activities of Miglitol. |
| Chlorpropamide | Stanozolol may increase the hypoglycemic activities of Chlorpropamide. |
| Nateglinide | Stanozolol may increase the hypoglycemic activities of Nateglinide. |
| Pentamidine | Stanozolol may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | Stanozolol may increase the hypoglycemic activities of Mifepristone. |
| Tolazamide | Stanozolol may increase the hypoglycemic activities of Tolazamide. |
| Repaglinide | Stanozolol may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | Stanozolol may increase the hypoglycemic activities of Phenformin. |
| Sulfamethoxazole | Stanozolol may increase the hypoglycemic activities of Sulfamethoxazole. |
| Glyburide | Stanozolol may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Stanozolol may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Stanozolol may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Stanozolol may increase the hypoglycemic activities of Tolbutamide. |
| Pioglitazone | Stanozolol may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | Stanozolol may increase the hypoglycemic activities of Bromocriptine. |
| Gliquidone | Stanozolol may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Stanozolol may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | Stanozolol may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | Stanozolol may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | Stanozolol may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Stanozolol may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Stanozolol may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Stanozolol may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Stanozolol may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Stanozolol may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Stanozolol may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Stanozolol may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Stanozolol may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Stanozolol may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Stanozolol may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Stanozolol may increase the hypoglycemic activities of Voglibose. |
| NN344 | Stanozolol may increase the hypoglycemic activities of NN344. |
| AMG-222 | Stanozolol may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Stanozolol may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | Stanozolol may increase the hypoglycemic activities of Alogliptin. |
| Dapagliflozin | Stanozolol may increase the hypoglycemic activities of Dapagliflozin. |
| Saxagliptin | Stanozolol may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | Stanozolol may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Stanozolol may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | Stanozolol may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | Stanozolol may increase the hypoglycemic activities of Canagliflozin. |
| Glibornuride | Stanozolol may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Stanozolol may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | Stanozolol may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | Stanozolol may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Stanozolol may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | Stanozolol may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Stanozolol may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Stanozolol may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Stanozolol may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | Stanozolol may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | Stanozolol may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Stanozolol may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Stanozolol may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Stanozolol may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Stanozolol may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Stanozolol may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Stanozolol may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Stanozolol may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | Stanozolol may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | Stanozolol may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Stanozolol may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Stanozolol may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Stanozolol may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Stanozolol may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Stanozolol may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Stanozolol may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Stanozolol may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | Stanozolol may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | Stanozolol may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Stanozolol may increase the hypoglycemic activities of Carbutamide. |